174 related articles for article (PubMed ID: 32673463)
21. Inhibiting rotavirus infection by membrane-impermeant thiol/disulfide exchange blockers and antibodies against protein disulfide isomerase.
Calderon MN; Guerrero CA; Acosta O; Lopez S; Arias CF
Intervirology; 2012; 55(6):451-64. PubMed ID: 22398681
[TBL] [Abstract][Full Text] [Related]
22. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.
Kawagishi T; Kanai Y; Nouda R; Fukui I; Nurdin JA; Matsuura Y; Kobayashi T
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907973
[TBL] [Abstract][Full Text] [Related]
23. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.
Feng N; Burns JW; Bracy L; Greenberg HB
J Virol; 1994 Dec; 68(12):7766-73. PubMed ID: 7966566
[TBL] [Abstract][Full Text] [Related]
24. Combination of the tumor angiogenesis inhibitor bevacizumab and intratumoral oncolytic herpes virus injections as a treatment strategy for human gastric cancers.
Deguchi T; Shikano T; Kasuya H; Nawa A; Fujiwara S; Takeda S; Gewen T; Sahin TT; Yamada S; Kanzaki A; Yamamura K; Fujii T; Sugimoto H; Nomoto S; Fukuda S; Nishikawa Y; Kodera Y; Nakao A
Hepatogastroenterology; 2012 Sep; 59(118):1844-50. PubMed ID: 22172413
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitory Effect of Histone Deacetylase Inhibitor SAHA on Proliferation of Mouse Multiple Myeloma Cell Line SP2/0 in vitro and in vivo].
Huo L; Zhang CY; Dang YF; Zhang WJ; Liu MM; Liu LS; Zhu ZM; Fang N; Ji SP; Sun K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):470-476. PubMed ID: 29665918
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.
Marchica V; Costa F; Donofrio G; Giuliani N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668361
[TBL] [Abstract][Full Text] [Related]
27. Systemic virotherapy for multiple myeloma.
Oliva S; Gambella M; Boccadoro M; Bringhen S
Expert Opin Biol Ther; 2017 Nov; 17(11):1375-1387. PubMed ID: 28796556
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.
Thirukkumaran CM; Shi ZQ; Nuovo GJ; Luider J; Kopciuk KA; Dong Y; Mostafa AA; Thakur S; Gratton K; Yang A; Chin AC; Coffey MC; Jimenez-Zepeda VH; Stewart D; Chesi M; Bergsagel PL; Morris D
Blood Adv; 2019 Mar; 3(5):797-812. PubMed ID: 30850386
[TBL] [Abstract][Full Text] [Related]
29. Serial propagation of porcine group C rotavirus (pararotavirus) in a continuous cell line and characterization of the passaged virus.
Saif LJ; Terrett LA; Miller KL; Cross RF
J Clin Microbiol; 1988 Jul; 26(7):1277-82. PubMed ID: 2842368
[TBL] [Abstract][Full Text] [Related]
30. A recombinant measles virus vaccine strain rMV-Hu191 has oncolytic effect against human gastric cancer by inducing apoptotic cell death requiring integrity of lipid raft microdomains.
Lv Y; Zhou D; Hao XQ; Zhu MY; Zhang CD; Zhou DM; Wang JH; Liu RX; Wang YL; Gu WZ; Shen HQ; Chen X; Zhao ZY
Cancer Lett; 2019 Sep; 460():108-118. PubMed ID: 31226409
[TBL] [Abstract][Full Text] [Related]
31. Cell culture propagation of porcine rotavirus (reovirus-like agent).
Theil KW; Bohl EH; Agnes AG
Am J Vet Res; 1977 Nov; 38(11):1765-8. PubMed ID: 201198
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene.
Fernandes MS; Gomes EM; Butcher LD; Hernandez-Alcoceba R; Chang D; Kansopon J; Newman J; Stone MJ; Tong AW
Clin Cancer Res; 2009 Aug; 15(15):4847-56. PubMed ID: 19622582
[TBL] [Abstract][Full Text] [Related]
33. Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma.
Stiff A; Caserta E; Sborov DW; Nuovo GJ; Mo X; Schlotter SY; Canella A; Smith E; Badway J; Old M; Jaime-Ramirez AC; Yan P; Benson DM; Byrd JC; Baiocchi R; Kaur B; Hofmeister CC; Pichiorri F
Mol Cancer Ther; 2016 May; 15(5):830-41. PubMed ID: 26809490
[TBL] [Abstract][Full Text] [Related]
34. Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid.
Hadac EM; Kelly EJ; Russell SJ
Mol Ther; 2011 Jun; 19(6):1041-7. PubMed ID: 21505425
[TBL] [Abstract][Full Text] [Related]
35. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
36. Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.
Munguia A; Ota T; Miest T; Russell SJ
Gene Ther; 2008 May; 15(10):797-806. PubMed ID: 18356812
[TBL] [Abstract][Full Text] [Related]
37. Expression of two bovine rotavirus non-structural proteins (NSP2, NSP3) in the baculovirus system and production of monoclonal antibodies directed against the expressed proteins.
Aponte C; Mattion NM; Estes MK; Charpilienne A; Cohen J
Arch Virol; 1993; 133(1-2):85-95. PubMed ID: 8240020
[TBL] [Abstract][Full Text] [Related]
38. Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3.
Sagara M; Miyamoto S; Itoh S; Soda Y; Tani K
Anticancer Res; 2021 Jan; 41(1):81-89. PubMed ID: 33419801
[TBL] [Abstract][Full Text] [Related]
39. Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.
Bourgeois-Daigneault MC; St-Germain LE; Roy DG; Pelin A; Aitken AS; Arulanandam R; Falls T; Garcia V; Diallo JS; Bell JC
Breast Cancer Res; 2016 Aug; 18(1):83. PubMed ID: 27503504
[TBL] [Abstract][Full Text] [Related]
40. Cultivation and characterization of three strains of murine rotavirus.
Greenberg HB; Vo PT; Jones R
J Virol; 1986 Feb; 57(2):585-90. PubMed ID: 3003390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
